Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- PAR-25-247
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.866 Aging Research
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Special District Governments
- Public or Indian Housing Auth.
- City/Township Governments
- For Profit Organizations
- Independent School Districts
- Non-501(c)(3) Nonprofits
- Higher Education Inst. (Private)
- 501(c)(3) Nonprofits
- Small Businesses
- County Governments
- Tribal Organizations (Not Federally Recognized)
- State Governments
- Tribal Governments (Federally Recognized)
- Other
- Higher Education Inst. (Public)
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institutes of Health seeks applicants for Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD-Related Dementias (PAR-25-247), with applications due September 25, 2026. This T32 training grant mechanism excludes clinical trials and is open to a broad range of eligible applicants including higher education institutions (public and private), 501(c)(3) and non-501(c)(3) nonprofits, small businesses, tribal governments and organizations, state and county governments, and other entity types; non-domestic entities and non-domestic components of U.S. organizations are not eligible.
The program promotes development of a diverse, interdisciplinary workforce for translational AD/ADRD research spanning target discovery through clinical development. Institutional training programs must support predoctoral and postdoctoral researchers with diverse educational backgrounds—including basic biology, translational and clinical research, and data science—and provide trainees with knowledge and skills in data science, disease biology, behavioral research, and traditional and emerging drug discovery disciplines necessary to conduct rigorous basic, translational, and clinical research on AD/ADRD.
Special consideration extends to Alaska Native and Native Hawaiian serving institutions, Asian American and Native American Pacific Islander serving institutions (AANAPISIs), Hispanic-serving institutions, historically Black colleges and universities (HBCUs), tribally controlled colleges and universities (TCCUs), faith-based and community-based organizations, and U.S. territories or possessions.
The opportunity falls under CFDA 93.866 (Aging Research). Award specifics including ceiling amounts, floor amounts, and expected number of awards are not detailed in the source material. Period of performance and place of performance are not specified.
Synopsis
3 versions
Update #3 · Latest ·
The specific purpose of this Notice of Funding Opportunity (NOFO) is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer's disease and Alzheimer's-related dementias from target discovery through clinical development. This NOFO will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e., basic biology, translational and clinical research, data science). The program invites eligible institutions to develop interdisciplinary training programs that will provide trainees with the knowledge and skills in data science, disease biology, behavioral research, and traditional and emerging drug discovery disciplines necessary to conduct rigorous and cutting-edge basic, translational, and clinical research for AD/ADRD.
Update #2 ·
Not available -
Not available
Update #1 ·
The specific purpose of this Notice of Funding Opportunity (NOFO) is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer's disease and Alzheimer's-related dementias from target discovery through clinical development. This NOFO will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e., basic biology, translational and clinical research, data science). The program invites eligible institutions to develop interdisciplinary training programs that will provide trainees with the knowledge and skills in data science, disease biology, behavioral research, and traditional and emerging drug discovery disciplines necessary to conduct rigorous and cutting-edge basic, translational, and clinical research for AD/ADRD.
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-247-Full-Announcement.html | HTML file | |
| PKG00289622.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity